ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

The March: Research Task Force Calls For $10 Billion NCI Budget In 5 Years

October 2, 1998

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992